LitCovid-PD-CLO  

PMC:7362084 / 80-631 JSONTXT 6 Projects

Antibody responses against SARS‐CoV‐2 in COVID‐19 patients LIU et al. Abstract Abstract The emerging coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has become a global pandemic, and brings formidable challenges to public health, society and the economy worldwide. Currently, the antibody responses against SARS‐CoV‐2 remains largely unknown. We herein estimated the longevity of specific antibodies against SARS‐CoV‐2, and reported that antibodies waned over substantially in COVID‐19 patients after recovery. This article is protected by copyright. All rights reserved.

Document structure show

Annnotations TAB TSV DIC JSON TextAE

  • Denotations: 2
  • Blocks: 0
  • Relations: 0